Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-13

Clinical Trial Update: Use of TXA to Prevent Postpartum Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tranexamic acid (TXA) to prevent postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TXA (tranexamic acid)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Post Partum Hemorrhage | Phase 2 | Status: UNKNOWN